Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells
about
Computational Approaches for the Discovery of Human Proteasome Inhibitors: An OverviewSynthesis and biological evaluation of naphthoquinone analogs as a novel class of proteasome inhibitorsThe Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membraneDiscovery and synthesis of hydronaphthoquinones as novel proteasome inhibitors.The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent mannerNew molecular targeted therapies for advanced non-small-cell lung cancer.MG132 inhibition of proteasome blocks apoptosis induced by severe DNA damage.Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the β-Catenin/Tcf4 InteractionSubstituted quinolines as noncovalent proteasome inhibitors.Discovery of PI-1840, a novel noncovalent and rapidly reversible proteasome inhibitor with anti-tumor activity.Proteasome inhibitors: an expanding army attacking a unique target.Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.Depletion of K-Ras promotes proteasome degradation of survivinFoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy.Selectively killing transformed cells through proteasome inhibition.Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.
P2860
Q26738752-BA05DD53-0230-43C6-A85A-BC836269C37FQ33629972-840DA174-9F82-41C3-908F-C66B2140BF1FQ34116730-9F6FEE05-1C48-4537-9C13-C21769925EBFQ34119207-8F6170C6-D100-485B-B32C-25536E32158BQ34685414-8D3954B5-FCDD-4B16-ADCB-40BBD258E566Q35667806-7A457D42-EDBB-433E-BCDF-FE0DE1B3CC22Q35695025-71F792E5-FD71-4361-9899-E218A3F1A54EQ35970241-77A538D3-F163-453D-ADCA-93A2C742A5E5Q35998619-73186294-E584-4645-BA03-5B1616662BF6Q37727613-495145D7-BF42-41D4-B06D-137E611DE70FQ37979388-D3FADDC4-C893-4D83-9177-EBDB4D7CBBBAQ39022882-BF962973-2651-4CD0-B7E2-AB24D588C9EAQ39209555-1A59C052-9D5E-4009-901D-E750B014B9C5Q39469423-F93E5F36-1420-478A-A574-6CBFAC19ED79Q43089411-10490952-0EF9-4DF9-BA68-2B2ECBDF06AEQ47631097-50502297-0F72-4598-999A-0F5C41EFF664
P2860
Discovery of a novel proteasome inhibitor selective for cancer cells over non-transformed cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Discovery of a novel proteasom ...... lls over non-transformed cells
@ast
Discovery of a novel proteasom ...... lls over non-transformed cells
@en
type
label
Discovery of a novel proteasom ...... lls over non-transformed cells
@ast
Discovery of a novel proteasom ...... lls over non-transformed cells
@en
prefLabel
Discovery of a novel proteasom ...... lls over non-transformed cells
@ast
Discovery of a novel proteasom ...... lls over non-transformed cells
@en
P2093
P2860
P356
P1433
P1476
Discovery of a novel proteasom ...... lls over non-transformed cells
@en
P2093
Aslamuzzaman Kazi
Gregory M Springett
Harshani Lawrence
Mark L McLaughlin
Norbert Berndt
Richard M L Yip
Saïd M Sebti
Wayne C Guida
P2860
P304
P356
10.4161/CC.8.12.8798
P577
2009-06-20T00:00:00Z